Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$1.85B |
| 2 |
Burlington
BURL
|
+$1.01B |
| 3 |
Philip Morris
PM
|
+$781M |
| 4 |
JPMorgan Chase
JPM
|
+$679M |
| 5 |
General Motors
GM
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.71B |
| 2 |
Netflix
NFLX
|
+$1.61B |
| 3 |
Illumina
ILMN
|
+$1.2B |
| 4 |
Mercado Libre
MELI
|
+$1.12B |
| 5 |
Amazon
AMZN
|
+$976M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Healthcare | 19.04% |
| 3 | Communication Services | 14.79% |
| 4 | Consumer Discretionary | 12.62% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CenterPoint Energy
CNP
$26.9B
| $433M | 0.13% |
22,398,382
+12,209,094
| +120% | +$240M |
|
152
Alexandria Real Estate Equities
ARE
$8.37B
| $433M | 0.13% |
2,707,038
-835
| -0% | -$139K |
|
153
NVR
NVR
$16.9B
| $432M | 0.13% |
105,824
+9
| +0% | +$34.7K |
|
154
Integra LifeSciences
IART
$1.44B
| $423M | 0.13% |
8,959,576
-370,870
| -4% | -$17.6M |
|
155
Haemonetics
HAE
$4.16B
| $421M | 0.13% |
4,825,515
+837,512
| +21% | +$73.2M |
|
156
CMS Energy
CMS
$22.1B
| $388M | 0.12% |
6,310,053
+1,149,596
| +22% | +$70.4M |
|
157
Texas Instruments
TXN
$253B
| $386M | 0.12% |
2,705,284
-100,190
| -4% | -$13.6M |
|
158
CrowdStrike
CRWD
$229B
| $384M | 0.12% |
11,181,420
+319,216
| +3% | +$9.3M |
|
159
Caesars Entertainment
CZR
$6.08B
| $375M | 0.11% |
+6,695,535
| New | +$294M |
|
160
Petrobras
PBR
$114B
| $368M | 0.11% |
51,733,339
-61,456
| -0.1% | -$522K |
|
|
IPHI
161
DELISTED
INPHI CORPORATION
IPHI
| $365M | 0.11% |
3,249,230
+234,156
| +8% | +$27.3M |
|
|
GWPH
162
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $363M | 0.11% |
3,732,712
+25,050
| +0.7% | +$2.88M |
|
163
Booking.com
BKNG
$159B
| $359M | 0.11% |
5,246,100
-883,825
| -14% | -$62.1M |
|
|
BLD
164
DELISTED
TopBuild
BLD
| $356M | 0.11% |
2,084,052
-91,376
| -4% | -$13.1M |
|
165
Qorvo
QRVO
$8.63B
| $353M | 0.11% |
2,733,215
+343,924
| +14% | +$42.6M |
|
|
AYX
166
DELISTED
Alteryx Inc
AYX
| $351M | 0.11% |
3,087,085
+659,870
| +27% | +$89.8M |
|
167
British American Tobacco
BTI
$124B
| $348M | 0.1% |
9,628,471
-8,470,550
| -47% | -$297M |
|
|
PRAH
168
DELISTED
PRA Health Sciences, Inc.
PRAH
| $347M | 0.1% |
3,422,071
+245,979
| +8% | +$25.1M |
|
169
Vertex Pharmaceuticals
VRTX
$133B
| $340M | 0.1% |
1,250,658
-1
| -0% | -$276 |
|
170
Cigna
CI
$73.8B
| $333M | 0.1% |
1,965,404
-981,235
| -33% | -$173M |
|
171
Helen of Troy
HELE
$701M
| $331M | 0.1% |
1,710,885
-59,401
| -3% | -$11.8M |
|
172
Johnson & Johnson
JNJ
$628B
| $321M | 0.1% |
2,156,134
-417
| -0% | -$61.7K |
|
173
Advanced Micro Devices
AMD
$808B
| $306M | 0.09% |
3,736,006
-833,087
| -18% | -$61.9M |
|
174
Penumbra
PEN
$12.9B
| $306M | 0.09% |
+1,572,825
| New | +$331M |
|
|
OPTU
175
Optimum Communications Inc
OPTU
$232M
| $303M | 0.09% |
11,670,715
-680,994
| -6% | -$17.7M |
|
Similar funds
Capital Research Global Investors's Q3 2020 Portfolio in Review
As of Q3 2020, Capital Research Global Investors held 426 positions worth $333B, up 5.4% from $316B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Research Global Investors's Q3 2020 filing shows 27 new, 161 increased, 170 reduced and 21 closed positions. Its largest new stake was Penumbra: 1,572,825 shares worth $306M. The largest sale was Meta Platforms (Facebook), an estimated $2.71B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
- Capital Research Global Investors's largest Q3 2020 buy was Penumbra: 1,572,825 shares worth $306M.
- Capital Research Global Investors added most to Comcast in Q3 2020, an estimated $1.85B increase.
- Capital Research Global Investors's biggest Q3 2020 reduction was Meta Platforms (Facebook), cutting an estimated $2.71B.
- Capital Research Global Investors fully exited Simon Property Group in Q3 2020, selling an estimated $245M.
- Capital Research Global Investors's ten largest holdings make up 34% of its $333B portfolio in Q3 2020.
- Capital Research Global Investors opened 27 new positions and closed 21 in Q3 2020.
- Capital Research Global Investors's portfolio value rose 5.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.